scispace - formally typeset
M

Murielle Colombet

Researcher at International Agency for Research on Cancer

Publications -  11
Citations -  9402

Murielle Colombet is an academic researcher from International Agency for Research on Cancer. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 10, co-authored 10 publications receiving 4963 citations.

Papers
More filters
Journal ArticleDOI

Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

TL;DR: The sources and methods used in compiling the cancer statistics in 185 countries are reviewed, and uncertainty intervals are now provided for the estimated sex‐ and site‐specific all‐ages number of new cancer cases and cancer deaths.
Journal ArticleDOI

Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018.

TL;DR: The present estimates of the cancer burden in Europe alongside a description of the profiles of common cancers at the national and regional level provide a basis for establishing priorities for cancer control actions across Europe.
Journal ArticleDOI

Cancer statistics for the year 2020: An overview

TL;DR: This paper reviewed the data sources and methods used in compiling the International Agency for Research on Cancer (IARC) GLOBOCAN cancer statistics for the year 2020 and summarised the main results.
Journal ArticleDOI

International incidence of childhood cancer, 2001-10 a population-based registry study

Eva Steliarova-Foucher, +229 more
- 01 Jun 2017 - 
TL;DR: This unique global source of childhood cancer incidence will be used for aetiological research and to inform public health policy, potentially contributing towards attaining several targets of the Sustainable Development Goals.
Journal ArticleDOI

Changing geographical patterns and trends in cancer incidence in children and adolescents in Europe, 1991–2010 (Automated Childhood Cancer Information System): a population-based study

TL;DR: Improvements in the diagnosis and registration of cancers over time could partly explain the observed increase in incidence, although some changes in underlying putative risk factors cannot be excluded.